Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Skyfish Drone Platform Achieves Blue UAS Cleared Status and Green UAS Certification
-
RadNet to Host Men's Health Webinar on June 13, 2026
-
KBR’s PureSAF® Technology Selected for Northen Europe’s Largest SAF and e-SAF Plant by NorSAF
-
EHang to Report First Quarter 2026 Unaudited Financial Results on Tuesday, June 9, 2026
-
Chop Steakhouse & Bar Opens Brand-New South Surrey Location, Marking 20th Restaurant in Chop’s 20th Year
-
Stoneshield Capital Closes Oversubscribed Opportunity Fund IV at €1.5 Billion Hard Cap
-
InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
-
Dave’s Hot Chicken Adds a Pop of Flavor with New Slushers Featuring Pop Rocks®
-
Net Asset Value
-
Transaction in Own Shares
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Scientists Reveal Ancient Coral Habitats and Deep-Sea Canyons off Newfoundland and Labrador Coast
-
Fortuna publishes its 2025 Sustainability Report
-
ESET Research APT Report: China-aligned groups spy in Venezuela and the Gulf, target AI robotics in S. Korea
-
Patton and Probity Partner to Protect Critical Infrastructure with Revolutionary New Data Diode Kit that Delivers NSA-Listed Security
-
AGS Celebrates 10 Straight Years as a Best and Brightest Company to Work For® in the Nation
-
Form 8.5 (EPT/RI)-NCC Group Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Bera hf.: Birting grunnlýsingar
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Form 8.5 (EPT/RI) - Alternative Income REIT Plc
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
DouYu International Holdings Limited Reports First Quarter 2026 Unaudited Financial Results
-
Li Auto Inc. Announces Unaudited First Quarter 2026 Financial Results
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 05 2026] - (CGWL)
-
Presentation materials for AB Civinity bond issue
-
Futu Announces First Quarter 2026 Unaudited Financial Results
-
Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
-
Willis: Leaders must move from caution to control as AI reshapes risk and resilience
-
XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters
-
SBTi validation of FLSmidth’s updated science-based targets
-
Stellar Alpina Raises CHF 3.5M to Build Detonation-Based Propulsion for Mobility After Launch
-
Share Buyback Transaction Details May 21 – May 27, 2026
-
Havila Kystruten AS: Notice of Annual General Meeting June 11th, 2026.
-
ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics
-
Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation
-
Fixico and Caliber join forces to reshape fleet repair in the United States
-
LIFT Files NI 43-101 Technical Report on the Adina-Galinée Lithium Project, Quebec, Canada
-
Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026
-
Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM
-
Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026
-
SCOR successfully sponsors a new catastrophe bond, Atlas Capital DAC Series 2026-1
-
Analyst report highlights Q1 2026 bookings of c.€2.5 million, implying an annualised run-rate above €10 million
-
ARKAY Beverages Expands Its Zero-Proof Portfolio With BEYOND SPIRITS and BEYOND WHISKY Plant-Based
-
Vilmorin & Cie receives a new round of long-term research financing from the European Investment Bank
-
Pulsar Helium Welcomes Landmark Minnesota Helium Regulation as Topaz Advances Toward First Production Amid Global Helium Shortage
-
NBPE Announces Transaction in Own Shares
-
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
-
Holding(s) in Company

